88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities 873 employees volunteered more than 3,600 hours across 7 Asian markets to support local communities. Employees partnered with 21 community organizations, positively impacting more than 4,300 people ... 2026-07-13T Health Care/Hospital Medical/Pharmaceuticals
Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases SHANGHAI , July 13, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical ... 2026-07-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 FORMER ELITE SOCCER PLAYERS SHOW EVIDENCE OF BRAIN HEALTH CHANGES IN MID-LIFE ... 2026-07-12T Health Care/Hospital Medical/Pharmaceuticals Trade show news
Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC NANJING, China , July 10, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the biologics license ... 2026-07-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Releases Positive Profit Alert for the First Half of 2026 CAMBRIDGE, Mass. , July 9, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" or the "Company", HKEX: 3696), a generative artificial intelligence (AI)-driven clinical-stage biotech ... 2026-07-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo HANGZHOU, China, SHANGHAI and BOSTON , July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on ... 2026-07-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations SAN DIEGO, July 9, 2026 /PRNewswire/ -- On the eve of the highly anticipated BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit successfully took place in San Diego. ... 2026-07-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026 MONTPELLIER, France , July 8, 2026 /PRNewswire/ -- Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's leading ... 2026-07-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production First antibody-drug conjugate facility to receive three provincial regulatory approvals for segmented manufacturing. Demonstrated a unified quality system, strict risk assessment protocols, and compliance ... 2026-07-08T Health Care/Hospital Medical/Pharmaceuticals
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards Seegene is launching the Global Million Clinical Study at the scale of one million test cases to shape disease-specific testing standards. The study is designed to evaluate the clinical utility of syndromic ... 2026-07-08T Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved